EVENT SERIES
Proteomics
Roundtable Series
Leading researchers will reveal how they are using high-throughput proteomics to drive real-world impact in population health and translational science. Register for upcoming live sessions below. Recordings will be available here after each presentation.
Is More Really More? Evaluating the Case for High-Plex, High-Quality Proteomics
June 6, 2025
Stephen Williams, MD, PhD, Chief Medical Officer at Standard BioTools hosts a panel featuring investigators from the 30-year, 500,000-participant EPIC cancer study. These researchers explain how they found “black swan” insights into the development of major cancers from proteins previously unmeasurable across massive cohorts.
View upcoming sessions below.
Quantifying Confidence: Comparative Metrics for Proteomic Platforms that Matter
COMING SOON
In this session, leading proteomics researchers will dive into differentiators in proteomics. From dispelling cross-reactivity myths to explaining head-to-head data, learn how researchers evaluate technologies for massive-scale studies.
Trusted at Scale: Deployment of Proteomic Technologies in Biobanks
COMING SOON
Find out how leading biobank researchers are translating large-scale proteomic data into real-world insights. As biobank investigators work to advance research across diverse populations, platform choice becomes mission-critical and focused on balancing throughput, reproducibility and depth of measurement.
Accelerating Drug Development: Proteomics in Clinical Trials
COMING SOON
Top biopharma innovators are using the SomaScan™ Assay to accelerate decision making and de-risk drug development, while getting closer to patients. Researchers will discuss how proteomics is delivering the insights they need to find better drugs, faster.
Interested in the next proteomics roundtable discussion?
Fill out the form below to get notified
For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2025 Standard BioTools Inc. All rights reserved.